Visual Pathway Outcomes in Clinical Neuroprotection Research
JAMA Neurology | Advancing Brain and Nervous System Science Blog
by
1w ago
This cohort study calculates clinical trial sample sizes powered by visual pathway outcomes of acute optic neuritis in neuroprotection research ..read more
Visit website
Error in Figure
JAMA Neurology | Advancing Brain and Nervous System Science Blog
by
1w ago
The Original Investigation titled “Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke: The ATAMIS Randomized Clinical Trial,” published on March 11, 2024, was corrected to fix the 95% CI for the overall risk difference reported in Figure 3 from −3.6% to 0.2% to is −3.6% to −0.2%. This article was corrected online ..read more
Visit website
Serologic Response to Epstein-Barr Virus Peptidome and Multiple Sclerosis Risk
JAMA Neurology | Advancing Brain and Nervous System Science Blog
by
1w ago
This case-control study assesses the serologic response to the Epstein-Barr virus peptidome before first symptoms of multiple sclerosis occur and whether specific epitopes may drive this response ..read more
Visit website
Treatment of Refractory Status Epilepticus With Continuous Intravenous Anesthetic Drugs
JAMA Neurology | Advancing Brain and Nervous System Science Blog
by
1w ago
This systematic review investigates the association between choice of initial continuous intravenous anesthetic drug and treatment failure, adverse events, and mortality in patients with refractory status epilepticus ..read more
Visit website
The Year in Review, 2023
JAMA Neurology | Advancing Brain and Nervous System Science Blog
by
1w ago
As we turn the page on 2023, we here at JAMA Neurology want to once again thank all of our readers, authors, and peer reviewers (who are listed elsewhere) for their continued support and contributions. Over the 7 years that our team has been fortunate enough to steward this amazing publication, our editorial team has overseen a transformation of the journal, with an eye toward incorporating your feedback to better meet your needs ..read more
Visit website
Is Incidentally Discovered Covert Cerebrovascular Disease Ignorable?
JAMA Neurology | Advancing Brain and Nervous System Science Blog
by
1w ago
This Viewpoint discusses the clinical implications of incidentally discovered covert cerebrovascular disease ..read more
Visit website
JAMA Neurology Peer Reviewers in 2023
JAMA Neurology | Advancing Brain and Nervous System Science Blog
by
1w ago
We sincerely thank the 709 peer reviewers who completed manuscript reviews for JAMA Neurology in 2023 ..read more
Visit website
Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy
JAMA Neurology | Advancing Brain and Nervous System Science Blog
by
1w ago
This cohort study investigates the risk of major congenital malformations associated with antiseizure medication (ASM) monotherapy in the offspring of mothers taking ASMs during pregnancy ..read more
Visit website
Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis
JAMA Neurology | Advancing Brain and Nervous System Science Blog
by
1w ago
This cross-sectional study examines findings from brain magnetic resonance imaging to identify the characteristics than can distinguish LGI1-antibody and CASPR2-antibody autoimmune encephalitis from viral encephalitis and Creutzfeldt-Jakob disease ..read more
Visit website
Discussion on the Application of Rapid Immunoblot Assay for AQP4-IgG Detection—Reply
JAMA Neurology | Advancing Brain and Nervous System Science Blog
by
1w ago
In Reply We thank Su and Wang for their valuable insights of our recent article on the rapid immunodot aquaporin 4 (AQP4) assay for neuromyelitis optica spectrum disorder (NMOSD ..read more
Visit website

Follow JAMA Neurology | Advancing Brain and Nervous System Science Blog on FeedSpot

Continue with Google
Continue with Apple
OR